6VFI image
Deposition Date 2020-01-05
Release Date 2020-08-12
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6VFI
Keywords:
Title:
De novo designed octahedral nanoparticle O43_dn18
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
4.54 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:O43_dn18A
Chain IDs:B (auth: A)
Chain Length:209
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:O43_dn18B
Chain IDs:A (auth: B)
Chain Length:121
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens.
Elife 9 ? ? (2020)
PMID: 32748788 DOI: 10.7554/eLife.57659

Abstact

Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo designed trimers tailored for antigen fusion, featuring N-terminal helices positioned to match the C termini of the viral glycoproteins. Trimers that experimentally adopted their designed configurations were incorporated as components of tetrahedral, octahedral, and icosahedral nanoparticles, which were characterized by cryo-electron microscopy and assessed for their ability to present viral glycoproteins. Electron microscopy and antibody binding experiments demonstrated that the designed nanoparticles presented antigenically intact prefusion HIV-1 Env, influenza hemagglutinin, and RSV F trimers in the predicted geometries. This work demonstrates that antigen-displaying protein nanoparticles can be designed from scratch, and provides a systematic way to investigate the influence of antigen presentation geometry on the immune response to vaccination.

Legend

Protein

Chemical

Disease

Primary Citation of related structures